FindTrial
Sign In

To Study the role of Serum Procalcitonin in determining the severity of Acute Pancreatitis

A Clinical Study of Acute Pancreatitis and Study of Serum Procalcitonin levels as a Marker of Severity in Acute Pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034141
Enrollment
118
Registered
2021-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K85- Acute pancreatitis

Interventions

None listed

Sponsors

Kasturba Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who fulfil the diagnostic criteria for acute pancreatitis and reporting within 48 hours of onset of initial

Exclusion criteria

Exclusion criteria: â?ª Patients with Chronic Pancreatitis, Recurrent Pancreatitis. â?ª Patients with severe burns or major trauma. â?ª Patients with severe or prolonged Cardiogenic shock. â?ª Patients with small cell lung cancer or medullary carcinoma thyroid. â?ª Patients with Chronic Kidney Disease.

Design outcomes

Primary

MeasureTime frame
The severity of acute pancreatitis in relation to the procalcitonin levelsTimepoint: Serum Procalcitonin levels will be assessed in the first 24 hrs. Severity is assessed at the end of 48Hrs—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Mahith Sai Reddy

Kasturba Medical College and Hospital

rvacharya@manipal.edu9845471000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026